About John Westwick
Form D filings for Recourse Biologics in 2024 list John Westwick as executive officer and director.
Form D filings also name John Westwick as a director at AskY Therapeutics.
John Westwick first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Westwick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Westwick works with at each company, as listed on that company's latest Form D.
Recourse Biologics, Inc. · Form D, Oct 8, 2024
AK
Alexander Krupnick
Director
DW
Daniel Watkins
President and Co-Chief Executive Officer, director
AskY Therapeutics, Inc. · Form D, Jun 4, 2024
AK
Alexander Krupnick
President and director
DW
Dan Watkins
Executive officer and director